Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Elevance Health, Inc. (ELV) had Revenue of $177.01B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$177.01B
Net Income	$5.98B
Cost of Goods Sold	$147.32B
Gross Profit	$29.69B
Operating Expenses	$167.92B
Operating Income	$9.09B
Non-Operating Income/Expense	$-1.19B
Pre-Tax Income	$7.90B
Normalized Pre-Tax Income	$7.90B
Income after Taxes	$5.97B
Income from Continuous Operations	$5.97B
Consolidated Net Income/Loss	$5.97B
Normalized Income after Taxes	$5.97B
EBIT	$9.09B
EBITDA	$10.48B
Weighted-Average Shares Outstanding (Basic)	231.70M
Weighted-Average Shares Outstanding (Diluted)	232.90M
Earnings per Share (EPS) (Basic)	$25.81
Earnings per Share (EPS) (Diluted)	$25.68
Balance Sheet Financials
Current Assets	$58.94B
Property, Plant, and Equipment	$4.65B
Long-Term Assets	$57.95B
Total Assets	$116.89B
Current Liabilities	$40.58B
Long-Term Debt	$29.22B
Long-Term Liabilities	$34.88B
Total Liabilities	$75.46B
Common Equity	$41.43B
Tangible Shareholders Equity	$1.05B
Shareholders Equity	$41.43B
Common Shares Outstanding	227.48M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$5.81B
Cash Flow from Investing Activities	$-5.17B
Cash Flow from Financial Activities	$1.19B
Beginning Cash	$6.46B
End Cash	$8.29B
Increase/Decrease in Cash	$1.83B
Stock-Based Compensation	$191.00M
Common Stock Dividends Paid	$-1.51B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.45
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.41
Debt to Equity Ratio	0.75
Gross Margin	16.78%
Operating Margin	5.13%
EBIT Margin	5.13%
EBITDA Margin	5.92%
Pre-Tax Profit Margin	4.47%
Profit Margin	3.38%
Free Cash Flow	$4.55B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.51
Inventory Turnover	--
Receiveable Turnover	9.28
Days Sales in Receivables	39.32
Return on Equity	14.41%
Return on Tangible Equity	565.97%
Return on Assets	5.11%
Return on Investments	8.45%
Book Value Per Share	$182.11
Free Cash Flow per Share	$19.54
Operating Cash Flow per Share	$24.94

Data from Zacks Investment Research, Inc.